Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparison of the new API Candida system to the ID 32C system for identification of clinically important yeast species.

Literature DB >> 8784609

Comparison of the new API Candida system to the ID 32C system for identification of clinically important yeast species.

H Fricker-Hidalgo¹, O Vandapel, M A Duchesne, M A Mazoyer, D Monget, B Lardy, B Lebeau, J Freney, P Ambroise-Thomas, R Grillot.

Abstract

API Candida was evaluated in comparison with the ID 32C system for the identification of 619 yeast isolates. The sensitivity of API Candida for the identification of the 15 species it claims to identify with and without additional tests was 97.4% (593 of 609) and 75.2% (458 of 609), respectively. The API Candida system is easy to use and rapid (result in 18 to 24 h).

Entities: Species

Mesh：

Year: 1996 PMID： 8784609 PMCID： PMC229134

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

18 in total

1. Evaluation of the ATB 32 C system for identification of clinical yeast isolates.

Authors: Brita Bruun; Henrik Westh; Jørgen Stenderup
Journal: Clin Microbiol Infect Date: 1995-02 Impact factor: 8.067

2. Evaluating biochemical identification systems.

Authors: J M Miller
Journal: J Clin Microbiol Date: 1991-08 Impact factor: 5.948

3. Evaluation of the modified API 20C system for identification of clinically important yeasts.

Authors: W J Buesching; K Kurek; G D Roberts
Journal: J Clin Microbiol Date: 1979-05 Impact factor: 5.948

4. Evaluation of the updated Vitek yeast identification data base.

Authors: M el-Zaatari; L Pasarell; M R McGinnis; J Buckner; G A Land; I F Salkin
Journal: J Clin Microbiol Date: 1990-09 Impact factor: 5.948

5. Evaluation of Albicans ID plates.

Authors: C De Champs; B Lebeau; P Ambroise-Thomas; R Grillot
Journal: J Clin Microbiol Date: 1995-08 Impact factor: 5.948

6. Candidemia in immunocompromised patients.

Authors: F Meunier; M Aoun; N Bitar
Journal: Clin Infect Dis Date: 1992-03 Impact factor: 9.079

7. Comparison of the Quantum II, API Yeast Ident, and AutoMicrobic systems for identification of clinical yeast isolates.

Authors: M A Pfaller; T Preston; M Bale; F P Koontz; B A Body
Journal: J Clin Microbiol Date: 1988-10 Impact factor: 5.948

8. Evaluation of the ATB 32C, automicrobic system and API 20C using clinical yeast isolates.

Authors: J Gutierrez; E Martin; C Lozano; J Coronilla; C Nogales
Journal: Ann Biol Clin (Paris) Date: 1994 Impact factor: 0.459

Review 9. Importance of Candida species other than C. albicans as pathogens in oncology patients.

Authors: J R Wingard
Journal: Clin Infect Dis Date: 1995-01 Impact factor: 9.079

10. Misidentification of clinical yeast isolates by using the updated Vitek Yeast Biochemical Card.

Authors: D P Dooley; M L Beckius; B S Jeffrey
Journal: J Clin Microbiol Date: 1994-12 Impact factor: 5.948

13 in total

Review 1. The ins and outs of DNA fingerprinting the infectious fungi.

Authors: D R Soll
Journal: Clin Microbiol Rev Date: 2000-04 Impact factor: 26.132

2. In vitro susceptibility of a large collection of Candida Strains against fluconazole and voriconazole by using the CLSI disk diffusion assay.

Authors: Ana Carolina Azevedo; Fernando César Bizerra; Daniel Arquimedes da Matta; Leila Paula de Almeida; Robert Rosas; Arnaldo Lopes Colombo
Journal: Mycopathologia Date: 2010-12-23 Impact factor: 2.574

Comparison of the new API Candida system to the ID 32C system for identification of clinically important yeast species.

1. Evaluation of the ATB 32 C system for identification of clinical yeast isolates.

2. Evaluating biochemical identification systems.

3. Evaluation of the modified API 20C system for identification of clinically important yeasts.

4. Evaluation of the updated Vitek yeast identification data base.

5. Evaluation of Albicans ID plates.

6. Candidemia in immunocompromised patients.

7. Comparison of the Quantum II, API Yeast Ident, and AutoMicrobic systems for identification of clinical yeast isolates.

8. Evaluation of the ATB 32C, automicrobic system and API 20C using clinical yeast isolates.

Review 9. Importance of Candida species other than C. albicans as pathogens in oncology patients.

10. Misidentification of clinical yeast isolates by using the updated Vitek Yeast Biochemical Card.

Review 1. The ins and outs of DNA fingerprinting the infectious fungi.

2. In vitro susceptibility of a large collection of Candida Strains against fluconazole and voriconazole by using the CLSI disk diffusion assay.

3. Efficacy of API 20C and ID 32C systems for identification of common and rare clinical yeast isolates.

4. Identification of Candida species by randomly amplified polymorphic DNA fingerprinting of colony lysates.

5. Evaluation of the VITEK 2 system for rapid identification of yeasts and yeast-like organisms.

6. Comparative study of seven commercial yeast identification systems.

7. Comparison of the API Candida system with the AUXACOLOR system for identification of common yeast pathogens.

8. Comparison of VITEK 2 with ITS2-fragment length polymorphism analysis for identification of yeast species.

9. Evaluation of six commercial systems for identification of medically important yeasts.

10. Evaluation of the new Micronaut-Candida system compared to the API ID32C method for yeast identification.